Areteia Therapeutics Announces Appointment of Daniel Becker, M.D., Ph.D. To Board of Directors

Contributed by: Business Wire

Logo

Images

(Photo: Business Wire)

Business Wire embedded0

Tags

Chemicals/Plastics

Clinical Trials

Manufacturing

Biotechnology

Alternative Medicine

Health

Pharmaceutical

Other Science

Science

asthma

More Like This

Areteia Therapeutics Announces Appointments of Donald J. Hayden, Jr. and Ian F. Smith to Its Board of Directors

Areteia Therapeutics Announces Additional $75MM in Series A Financing for Oral Dexpramipexole in Eosinophilic Asthma

Areteia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday January 14, 2025

Areteia Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024

Daniel G. Welch (Photo: Business Wire)

Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate

iTeos Therapeutics Announces Appointment of David Feltquate as Chief Medical Officer

EGLE Therapeutics Strengthens its Board of Directors with the Appointment of Michel Detheux, Ph.D., as Independent Chairman Board Member, and with the Appointment of Mojgan Hossein-Nia, Ph.D. as Board Member Representative of Takeda Ventures

iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates